Open AccessPredictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial
Author(s) -
Eisen Alon,
Can Christopher P.,
Braunwald Eugene,
Steen Dylan L.,
Zhou Jing,
Goodrich Erica L.,
Im KyungAh,
Dalby Anthony J.,
Spinar Jindrich,
Daga Shruti,
Lukas Mary Ann,
O'Donoghue Michelle L.
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004332
Subject(s) - medicine , timi , thrombolysis , acute coronary syndrome , cardiology , myocardial infarction , statin , atorvastatin
High-potency statins reduce cardiovascular events after acute coronary syndromes but remain underused in clinical practice. We examined predictors of nonuse of high-potency statins after acute coronary syndromes.